Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > News > Nanogen Shares Nosedive as Q2 Loss Nearly Doubles

August 4th, 2004

Nanogen Shares Nosedive as Q2 Loss Nearly Doubles

Abstract:
Nanogen Inc., maker of the NanoChip molecular diagnostics system for biologic research, saw its stock drop nearly 21 percent today after posting a second-quarter loss that almost doubled its loss of a year ago. Nanogen shares (Nasdaq: NGEN) fell 99 cents, or 20.6 percent, to close at $3.81 today. The firm has a market cap of $97.65 million.

Source:
sandiego.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Financial Reports

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 First Quarter Results January 31st, 2017

Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 7, 2017 January 19th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Harris & Harris Group Issues Business Update and Reports Financial Statements as of September 30, 2016 November 9th, 2016

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project